TCF4 (Transcription Factor 4), also known as ITF2 (Immunoglobulin Transcription Factor 2) or SEF2-1, is a basic helix-loop-helix (bHLH) transcription factor encoded by the TCF4 gene on chromosome 18q21.2[@flora2007]. TCF4 is a member of the E-protein family of transcription factors and plays critical roles in neurodevelopment, synaptic plasticity, and cellular homeostasis. Mutations in TCF4 cause Pitt-Hopkins syndrome, a severe neurodevelopmental disorder, and GWAS have identified TCF4 variants as risk factors for both Alzheimer's disease and schizophrenia[@steinberg2012].
Gene Structure and Expression
The TCF4 gene spans approximately 20 kb and contains 20 exons. It encodes multiple isoforms ranging from 667 to 1,010 amino acids through alternative splicing. The protein contains:
N-terminal transcriptional activation domain: Rich in proline and glutamine
TCF4 is implicated in AD pathogenesis through multiple mechanisms:
Amyloid regulation: TCF4 binds to the APP gene promoter and influences amyloid precursor protein expression. Altered TCF4 activity may contribute to dysregulated Aβ production[@de2013].
Tau metabolism: TCF4 interacts with tau splicing regulators and affects the inclusion of exon 10 in MAPT transcripts, potentially influencing the 3R/4R tau ratio.
Neuroinflammation: As a transcription factor in microglia, TCF4 regulates inflammatory cytokine expression. TCF4 variants may enhance pro-inflammatory responses.
Synaptic dysfunction: TCF4 target genes include critical synaptic proteins, and dysregulation contributes to synaptic loss.
Parkinson's Disease
Emerging evidence links TCF4 to PD:
Dopaminergic neuron development: TCF4 is expressed in the substantia nigra and regulates genes critical for dopamine neuron survival.
α-Synuclein transcription: TCF4 may regulate SNCA (α-synuclein) expression, with polymorphisms affecting aggregate formation.